Viking Therapeutics, Inc. (VKTX)

Last Closing Price: 26.17 (2026-11-18)

Stock-Based Compensation (Quarterly)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

Viking Therapeutics, Inc. (VKTX) had Stock-Based Compensation of $39.36M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-183.19M
--
--
$187.11M
$-187.11M
$3.93M
$-183.19M
$-183.19M
$-183.19M
$-183.19M
$-183.19M
$-183.19M
$-187.11M
$-187.75M
118.05M
118.05M
$-1.55
$-1.55
Balance Sheet Financials
$973.00M
--
$4.17M
$977.17M
$133.90M
$250.66M
$254.67M
$388.57M
$588.60M
$588.60M
$588.60M
127.52M
Cash Flow Statement Financials
$-377.34M
$256.14M
$633.21M
$165.81M
$677.81M
$512.00M
Stock-Based Compensation
$39.36M
--
--
Fundamental Metrics & Ratios
7.27
--
--
0.30
0.43
--
--
--
--
--
--
$-377.34M
--
--
--
--
--
--
--
-31.12%
-31.12%
-18.75%
-21.83%
$4.62
$-3.20
$-3.20